2026-01-01 - Analysis Report
Okay, here's a comprehensive report on Intuitive Surgical (ISRG) based on the data provided.

**Report on Intuitive Surgical (ISRG)**

**Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets robotic surgical systems, primarily the da Vinci Surgical System.

**1) Return Rate Comparison:**

*   **ISRG Cumulative Return:** 111.62%
*   **S&P 500 (VOO) Cumulative Return:** 102.21%
*   **Divergence:** 9.4 (Relative Divergence: 34.5)

**Analysis:** ISRG has outperformed the S&P 500 over the period examined, with a cumulative return 9.4% higher. The relative divergence of 34.5 indicates that the current divergence is not near the high end of its historical range.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha | Beta  | Cap(B) |
|------------|--------|-------|-------|-------|--------|
| 2024-2026 | 112.0% | 80.4% | 6.0%  | -0.1 | 204.9  |

**Analysis:**

*   **CAGR:** The high CAGR of 112% indicates substantial growth.
*   **MDD:** The Maximum Drawdown (MDD) of 80.4% indicates significant potential downside risk.
*   **Alpha:** The positive Alpha of 6.0% suggests that ISRG has outperformed its benchmark (likely the S&P 500) on a risk-adjusted basis.
*   **Beta:** The negative Beta of -0.1 suggests ISRG has very low correlation with the overall market, and may move in the opposite direction of the market.
*   **Cap(B):** A market capitalization of 204.9 billion suggests Intuitive Surgical is a large-cap company.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** $572.63
*    **Last-market:** {'price': 571.46, 'previousClose': 572.63, 'change': -0.2}
*   **5-day SMA:** $576.07
*   **20-day SMA:** $565.87
*   **60-day SMA:** $536.02

**Analysis:** The stock price is currently below its 5-day SMA, but above its 20-day and 60-day SMAs. This suggests a short-term downward trend, but with longer-term upward momentum. Last-market price is lower than the current close.

**3) Indicator Analysis:**

*   **Market Risk Indicator (MRI):** 0.9 (Medium Investment)
*   **RSI:** 60.11 (Neutral)
*   **PPO:** 0.0062 (Relatively Neutral)
*   **Hybrid Signal:** Cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** -2.4 (Short-term Decline)
*   **Expected Return:** 25.3%

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI is slightly above 50, indicating a neutral to slightly bullish momentum.
*   The PPO is close to zero, suggesting neither strong overbought nor oversold conditions.
*   The hybrid signal suggests a strong buy.
*   The recent decline in relative divergence suggests the stock has underperformed the S&P 500 recently.
*   The expected return of 25.3% is attractive and suggests potential long-term gains.

**4) Recent News & Significant Events (Yahoo Finance):**

*   **Intuitive Surgical Shares Sold by Oak Asset Management:** Suggests some institutional investors are reducing their positions.
*   **Intuitive Surgical Stock Hits Key Support:**  Indicates a potential buying opportunity based on technical analysis.
*   **ISRG Sees 91% SP Growth:** A positive signal related to Single-Port surgery advancements.
*   **Intuitive Surgical Stock: Buy Opportunity or Risk Ahead:** A balanced view, suggesting both potential and risks.
*   **ISRG Stock Forms Golden Crossover:**  A bullish technical indicator suggesting a potential uptrend.
*   **ISRG Pre-Market: Innovations in AI Surgical Systems:** Highlighting potential growth drivers.

**Analysis:** Recent news is a mixed bag. Some indicate potential buying opportunities and positive growth drivers (AI, Single-Port surgery), while others suggest caution (institutional selling).

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 2.06)
*   **Target Price:** Avg: $599.60, High: $700.00, Low: $378.00

**Analysis:** Analyst consensus is generally positive with a "Buy" rating. The average target price suggests potential upside from the current price. The range of target prices is quite wide, indicating some uncertainty among analysts.

**5) Recent Earnings Analysis:**

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-10-22 | 1.98 | 2.51 B$  |
| 2025-07-23 | 1.84 | 2.44 B$  |
| 2025-04-23 | 1.95 | 2.25 B$  |
| 2024-10-18 | 1.59 | 2.04 B$  |
| 2025-10-22 | 1.59 | 2.04 B$  |

**Analysis:** Both EPS and Revenue have generally increased over the past year, indicating healthy growth. The first entry of 2025-10-22 looks suspicious and should be reviewed with the prior year's value from 2024-10-18.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-09-30 | $2.51B  | 66.36%         |
| 2025-06-30 | $2.44B  | 66.31%         |
| 2025-03-31 | $2.25B  | 64.69%         |
| 2024-12-31 | $2.41B  | 68.04%         |
| 2024-09-30 | $2.04B  | 67.41%         |

**Capital and Profitability:**

| Quarter    | Equity    | ROE   |
|------------|-----------|-------|
| 2025-09-30 | $16.93B   | 4.16% |
| 2025-06-30 | $17.85B   | 3.69% |
| 2025-03-31 | $17.11B   | 4.08% |
| 2024-12-31 | $16.43B   | 4.17% |
| 2024-09-30 | $15.58B   | 3.63% |

**Analysis:**

*   **Revenue:**  Revenue has shown a consistent upward trend over the past year.
*   **Profit Margin:**  Profit margins remain very strong, consistently above 64%.
*   **Equity:** Equity has fluctuated but generally increased.
*   **ROE:** Return on Equity (ROE) has remained relatively stable, indicating consistent profitability relative to shareholder equity.

**7) Comprehensive Analysis (Summary):**

Intuitive Surgical (ISRG) is a high-growth company with a strong market position, as reflected in its outperformance against the S&P 500. Its financials are robust, with increasing revenue and high profit margins. Analyst ratings are generally positive.

**Key Positives:**

*   Strong historical performance and outperformance vs. S&P 500.
*   High CAGR.
*   Positive analyst ratings and target prices.
*   Consistent revenue growth and high profit margins.
*   Innovations in AI and Single-Port surgery.

**Key Risks/Concerns:**

*   High Maximum Drawdown (MDD) indicating potential volatility.
*   Recent institutional selling.
*   Short-term downward trend in stock price.
*   Duplicated entry in recent earnings analysis may suggest potential data integrity issue.

**Overall:**

ISRG appears to be a fundamentally strong company with attractive growth prospects. However, investors should be aware of the potential for volatility and monitor news and technical indicators closely. The data indicates a medium level of investment risk. The duplicated entry should be verified, if possible.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.